0001179110-12-012053.txt : 20120801 0001179110-12-012053.hdr.sgml : 20120801 20120801121750 ACCESSION NUMBER: 0001179110-12-012053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120731 FILED AS OF DATE: 20120801 DATE AS OF CHANGE: 20120801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEMA CATHY CENTRAL INDEX KEY: 0001181157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 12999179 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0306 4 2012-07-31 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001181157 KLEMA CATHY 300 CENTRAL PARK WEST NEW YORK NY 10024 1 0 0 0 Common Stock, par value $0.0033 2012-07-31 4 M 0 11700 44.14 A 39432 D Common Stock, par value $0.0033 2012-07-31 4 M 0 5000 30.12 A 44432 D Common Stock, par value $0.0033 2012-07-31 4 M 0 5000 29.03 A 49432 D Common Stock, par value $0.0033 2012-07-31 4 S 0 11700 78.38 D 37732 D Common Stock, par value $0.0033 2012-07-31 4 S 0 5000 78.38 D 32732 D Common Stock, par value $0.0033 2012-07-31 4 S 0 5000 78.38 D 27732 D Non-Qualified Options to Purchase Common Stock 44.14 2012-07-31 4 M 0 11700 0 D 2005-05-20 2014-03-26 Common Stock, par value $0.0033 11700 0 D Non-Qualified Options to Purchase Common Stock 30.12 2012-07-31 4 M 0 5000 0 D 2006-06-29 2015-06-29 Common Stock, par value $0.0033 5000 0 D Non-Qualified Options to Purchase Common Stock 29.03 2012-07-31 4 M 0 5000 0 D 2007-05-05 2016-05-05 Common Stock, par value $0.0033 5000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.28 to $78.52, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/CATHERINE M. KLEMA 2012-08-01